T1	Participants 168 204	among individuals with heart failure
T2	Participants 322 343	Boston, Massachusetts
T3	Participants 500 538	individuals with stable heart failure.
T4	Participants 612 624	100 patients
T5	Participants 1678 1731	Among patients undergoing treatment for heart failure
